Finance

Beta
Lists
ZBH:NYSE
Zimmer Biomet Holdings, Inc
USD 87,97
+0,93%
(+0,81) 1D
USD 87,97
0,00% (0,00)
After hours
Closed: 18 Jun., 16:00:08 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZBH...
Open
USD 87,85
High
USD 88,81
Low
USD 87,32
Mkt. cap
17,02 mjd
Avg. vol.
2,19 m
Volume
4,63 m
Dividend
1,09%
Quarterly dividend
USD 0,24
Ex-dividend date
25 Jun. 2026
P/E ratio
22,85
52-wk high
USD 108,29
52-wk low
USD 79,12
EPS
USD 3,85
Beta
0,47
Shares outstanding
193,46 m
No. of employees
17 k
Open
USD 87,85
High
USD 88,81
Low
USD 87,32
Mkt. cap
17,02 mjd
Avg. vol.
2,19 m
Volume
4,63 m
Dividend
1,09%
Quarterly dividend
USD 0,24
Ex-dividend date
25 Jun. 2026
P/E ratio
22,85
52-wk high
USD 108,29
52-wk low
USD 79,12
EPS
USD 3,85
Beta
0,47
Shares outstanding
193,46 m
No. of employees
17 k
Analyst outlook
Analyst Ratings
Based on 16 analysts giving stock ratings to ZBH in the past 3 months
Hold
Buy
4
Hold
11
Sell
1
12 month forecast
Based on 16 Wall Street analysts offering 12 month price targets for ZBH in the last 3 months.
Highest
Current USD 87,97
USD 109,00 (+23,91%)
Average
USD 96,92 (+10,17%)
Lowest
USD 83,00 (-5,65%)
News stories
From sources across the web
Profile
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook. Wikipedia
About Zimmer Biomet Holdings, Inc
CEOIvan Tornos
Employees17 k
Founded1927
HeadquartersWarsaw, Indiana, Verenigde State van Amerika
SectorMedical device
Websitezimmerbiomet.com
Last report
28 Apr. 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
USD 2,09 / USD 1,86
+12,21%beat
Revenue / Est. (USD)
2,09 mjd / 2,07 mjd
+0,83%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
2,08 mjd
2,00 mjd
2,24 mjd
2,09 mjd
Cost of goods sold
590,70 m
559,30 m
795,50 m
564,20 m
Cost of revenue
590,70 m
559,30 m
795,50 m
564,20 m
Research and development expenses
113,30 m
115,90 m
118,70 m
103,40 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
807,20 m
809,40 m
838,50 m
846,20 m
Operating expense
1,08 mjd
1,10 mjd
1,13 mjd
1,11 mjd
Total operating expenses
1,67 mjd
1,66 mjd
1,93 mjd
1,68 mjd
Operating income
405,50 m
340,30 m
313,40 m
410,80 m
Other non operating income
3,60 m
6,20 m
15,10 m
5,50 m
EBT including unusual items
224,60 m
279,20 m
97,90 m
301,30 m
EBT excluding unusual items
327,80 m
269,30 m
250,00 m
340,20 m
Income tax expense
71,20 m
48,00 m
-39,90 m
63,00 m
Effective tax rate
31,70%
17,19%
-40,76%
20,91%
Other operating expenses
-
-
-
-
Net income
152,80 m
230,90 m
139,30 m
238,10 m
Net profit margin
7,36%
11,54%
6,21%
11,41%
Earnings per share
2,07
1,90
2,42
2,09
Interest and investment income
-
-
-
-
Interest expense
-79,30 m
-75,40 m
-71,90 m
-68,80 m
Net interest expenses
-79,30 m
-75,40 m
-71,90 m
-68,80 m
Depreciation and amortization charges
-
-
-
-
EBITDA
677,30 m
623,90 m
597,40 m
680,80 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer